AU2001285376A1 - System and method for tracking and controlling infections - Google Patents

System and method for tracking and controlling infections

Info

Publication number
AU2001285376A1
AU2001285376A1 AU2001285376A AU8537601A AU2001285376A1 AU 2001285376 A1 AU2001285376 A1 AU 2001285376A1 AU 2001285376 A AU2001285376 A AU 2001285376A AU 8537601 A AU8537601 A AU 8537601A AU 2001285376 A1 AU2001285376 A1 AU 2001285376A1
Authority
AU
Australia
Prior art keywords
tracking
controlling infections
infections
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285376A
Inventor
Barry N. Kreiswirth
Steven M. Naidich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
eGenomics Inc
Original Assignee
eGenomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by eGenomics Inc filed Critical eGenomics Inc
Publication of AU2001285376A1 publication Critical patent/AU2001285376A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Primary Health Care (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Databases & Information Systems (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Bioethics (AREA)
  • Biomedical Technology (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001285376A 2000-09-06 2001-09-06 System and method for tracking and controlling infections Abandoned AU2001285376A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09656084 2000-09-06
US09/656,084 US7349808B1 (en) 2000-09-06 2000-09-06 System and method for tracking and controlling infections
PCT/US2001/027568 WO2002020827A1 (en) 2000-09-06 2001-09-06 System and method for tracking and controlling infections

Publications (1)

Publication Number Publication Date
AU2001285376A1 true AU2001285376A1 (en) 2002-03-22

Family

ID=24631546

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285376A Abandoned AU2001285376A1 (en) 2000-09-06 2001-09-06 System and method for tracking and controlling infections

Country Status (5)

Country Link
US (2) US7349808B1 (en)
EP (1) EP1315828B1 (en)
AU (1) AU2001285376A1 (en)
CA (1) CA2421523C (en)
WO (1) WO2002020827A1 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020120408A1 (en) * 2000-09-06 2002-08-29 Kreiswirth Barry N. System and method for tracking and controlling infections
US7349808B1 (en) 2000-09-06 2008-03-25 Egenomics, Inc. System and method for tracking and controlling infections
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7666588B2 (en) * 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20040121313A1 (en) * 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US8073627B2 (en) * 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
EP1375678A3 (en) * 2002-06-14 2004-03-10 Agilent Technologies, Inc. Methods and compositions for performing array based assays
EP1578399A4 (en) 2002-12-06 2007-11-28 Isis Pharmaceuticals Inc Methods for rapid identification of pathogens in humans and animals
US7951409B2 (en) 2003-01-15 2011-05-31 Newmarket Impressions, Llc Method and apparatus for marking an egg with an advertisement, a freshness date and a traceability code
US8046171B2 (en) * 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) * 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) * 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US20040248106A1 (en) * 2003-06-06 2004-12-09 Leonard Leslie A. Clinical array assays that include a sample quality evaluation step and compositions for use in practicing the same
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US20060240412A1 (en) * 2003-09-11 2006-10-26 Hall Thomas A Compositions for use in identification of adenoviruses
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20100035239A1 (en) * 2003-09-11 2010-02-11 Isis Pharmaceuticals, Inc. Compositions for use in identification of bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) * 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) * 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
WO2005117270A2 (en) * 2004-05-24 2005-12-08 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) * 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US20060229822A1 (en) * 2004-11-23 2006-10-12 Daniel Theobald System, method, and software for automated detection of predictive events
US8084207B2 (en) * 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
CA2600184A1 (en) 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious viruses
AU2006272776B2 (en) * 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
WO2007076426A1 (en) * 2005-12-21 2007-07-05 Tokman Michael G Method of identifying clusters and connectivity between clusters
WO2007106588A2 (en) * 2006-03-15 2007-09-20 Fullpower Technologies, Inc. Method and apparatus to provide outbreak notification based on historical location data
AU2007353877B2 (en) * 2006-09-14 2012-07-19 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
EP2126132B1 (en) * 2007-02-23 2013-03-20 Ibis Biosciences, Inc. Methods for rapid foresnsic dna analysis
US20100204266A1 (en) * 2007-03-23 2010-08-12 Ibis Biosciences, INC Compositions for use in identification of mixed populations of bioagents
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
WO2009085473A2 (en) 2007-11-21 2009-07-09 Cosmosid Inc. Genome identification system
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
US8148163B2 (en) * 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
EP2359289A4 (en) * 2008-11-26 2015-11-11 Illumina Inc Methods and systems for analysis of sequencing data
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc Ionization probe assemblies
US9194877B2 (en) 2009-07-17 2015-11-24 Ibis Biosciences, Inc. Systems for bioagent indentification
WO2011008971A1 (en) * 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
US20110091882A1 (en) * 2009-10-02 2011-04-21 Ibis Biosciences, Inc. Determination of methylation status of polynucleotides
EP2488656B1 (en) * 2009-10-15 2015-06-03 Ibis Biosciences, Inc. Multiple displacement amplification
NZ599873A (en) 2009-10-19 2014-09-26 Theranos Inc Integrated health data capture and analysis system
WO2012002435A1 (en) * 2010-06-30 2012-01-05 株式会社ニコン Infection spread prevention support system, infection spread prevention support server, examination terminal, mobile terminal and program
US8956858B2 (en) 2013-03-14 2015-02-17 Src, Inc. Tactical and portable PCR/HRM genome identification system
US9323895B2 (en) 2013-05-31 2016-04-26 International Business Machines Corporation Healthcare management
US10347382B2 (en) * 2014-09-29 2019-07-09 Athenahealth, Inc. Methods and apparatus for geography-based antimicrobial resistance tracking
US10741278B2 (en) 2015-04-20 2020-08-11 Cardeya Corporation Pathogen detection and display system
MX2018000171A (en) 2015-07-13 2018-03-26 Koninklijke Philips Nv Tracking infections in hospital environments.
WO2017177111A1 (en) * 2016-04-08 2017-10-12 Rdb Bioinformatics, Llc A multi-level, laboratory-based surveillance system for detection of intraoperative "eskape" bacterial pathogens for hcai prevention
US20190333646A1 (en) * 2016-07-15 2019-10-31 Knox Spencer Associates Llc Systems and methods for determining, tracking, and predicting common infectious illness outbreaks
EP3616215A1 (en) * 2017-04-27 2020-03-04 Koninklijke Philips N.V. Use of clinical knowledge to improve use of next generation sequencing
US12007732B2 (en) 2019-07-12 2024-06-11 Johnson Controls Tyco IP Holdings LLP HVAC system with building infection control
US11960261B2 (en) 2019-07-12 2024-04-16 Johnson Controls Tyco IP Holdings LLP HVAC system with sustainability and emissions controls
US11761660B2 (en) 2019-01-30 2023-09-19 Johnson Controls Tyco IP Holdings LLP Building control system with feedback and feedforward total energy flow compensation
WO2021011497A1 (en) 2019-07-12 2021-01-21 Johnson Controls Technology Company Hvac system with design and operational tool for building infection control
US11714393B2 (en) 2019-07-12 2023-08-01 Johnson Controls Tyco IP Holdings LLP Building control system with load curtailment optimization
US11274842B2 (en) 2019-07-12 2022-03-15 Johnson Controls Tyco IP Holdings LLP Systems and methods for optimizing ventilation, filtration, and conditioning schemes for buildings
WO2021233996A1 (en) * 2020-05-19 2021-11-25 Alacris Theranostics Gmbh Method and system for fighting pandemic
WO2021242911A1 (en) * 2020-05-26 2021-12-02 Pangolin Llc Wastewater system to monitor pathogens and methods of use
DE102020210490A1 (en) * 2020-06-16 2021-12-16 HealthVision GmbH Procedure and system for infection control in a restricted area
US11664130B2 (en) 2020-09-01 2023-05-30 International Business Machines Corporation Predicting infection risk using heterogeneous temporal graphs
US11818624B1 (en) 2020-11-19 2023-11-14 Wells Fargo Bank, N.A. System and methods for passive contact tracing
US11139063B1 (en) * 2020-12-29 2021-10-05 Kpn Innovations, Llc. Systems and methods for generating a microbiome balance plan for prevention of bacterial infection
CN112687344B (en) * 2021-01-21 2021-09-10 予果生物科技（北京）有限公司 Human adenovirus molecule typing and tracing method and system based on metagenome

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266944A (en) * 1991-06-26 1993-11-30 Bodyguard Technologies, Inc. Electronic system and method for monitoring abusers for compliance with a protective order
DE69231646T2 (en) 1991-10-23 2001-06-13 Baylor College Of Medicine, Houston FINGERPRINT-LIKE IDENTIFICATION OF BACTERIA STRAINS BY AMPLIFICATING REPETITIVE DNA SEQUENCES
US5660981A (en) 1994-06-06 1997-08-26 E. I. Du Pont De Nemours And Company Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella
US5619991A (en) * 1995-04-26 1997-04-15 Lucent Technologies Inc. Delivery of medical services using electronic data communications
JP2002529046A (en) 1997-05-06 2002-09-03 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Enterococcus faecalis polynucleotides and polypeptides
AU6750198A (en) * 1998-04-03 1999-10-25 Seed Capital Investments-2 (Sci-2) B.V. A method of interstrain differentiation of bacteria
EP1268774A2 (en) 2000-03-21 2003-01-02 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
US6404340B1 (en) * 2000-06-19 2002-06-11 Massachusetts Institute Of Technology Multiple-axis tracking of passive resonant structures
US7349808B1 (en) 2000-09-06 2008-03-25 Egenomics, Inc. System and method for tracking and controlling infections

Also Published As

Publication number Publication date
CA2421523C (en) 2017-03-14
EP1315828B1 (en) 2018-04-11
US7349808B1 (en) 2008-03-25
US20080206767A1 (en) 2008-08-28
US8046172B2 (en) 2011-10-25
EP1315828A1 (en) 2003-06-04
EP1315828A4 (en) 2005-06-29
CA2421523A1 (en) 2002-03-14
WO2002020827A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001285376A1 (en) System and method for tracking and controlling infections
AU2003215184A1 (en) System and method for tracking and controlling infections
AU2001288372A1 (en) System and method for tele-ophthalmology
AU2001255198A1 (en) Method and system for situation tracking and notification
AU2002308710A1 (en) Method and system for affiliate tracking
AU2002323310A1 (en) Method and system for transferring stored value
AU2002307768A1 (en) System and method for phytomonitoring
AU2002210309A1 (en) Image tracking system and method
AU2002214667A1 (en) System and method for rapid telepositioning
AU2001282586A1 (en) Freight tracking method and freight tracking system
AU2002361342A1 (en) System and method for selecting access point
AU2002234211A1 (en) Position location system and method
AU7755900A (en) Method and system for device status tracking
AU2001257572A1 (en) Method and system for account activation
AU2001267188A1 (en) System and method for transferring funds
AU2002226090A1 (en) Method and system for adaptive prefetching
AU7871500A (en) Method and system for device tracking
AU2002230705A1 (en) System and method for push-model fund transfers
AU2001257380A1 (en) System and method for application object transport
AU2001263129A1 (en) System and method for orthokeratology
WO2002023370A8 (en) Optimization method and system
AU2002222170A1 (en) Method and system for icosaborane implantation
AU2001291039A1 (en) Method and system for tracking assets
AU2002213227A1 (en) Generalizer system and method
AU2002236609A1 (en) System and method for transaction access control